Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-07-28
2008-11-11
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S198000
Reexamination Certificate
active
07449482
ABSTRACT:
The present invention provides methods for the use of compounds as depicted by structure I, pharmaceutical compositions containing the same, and methods for the prophylaxis, management and treatment of metabolic diseases and diseases modulated by MCD inhibition. The compounds disclosed in this invention are useful for the prophylaxis, management and treatment of diseases involving in malonyl-CoA regulated glucose/fatty acid metabolism pathway. In particular, these compounds and pharmaceutical composition containing the same are indicated in the prophylaxis, management and treatment of cardiovascular diseases, diabetes, cancer and obesity.
REFERENCES:
patent: 3728455 (1973-04-01), Kupfer
patent: 5177097 (1993-01-01), Poss
patent: 5190942 (1993-03-01), Poss
patent: 5208234 (1993-05-01), Poss
patent: 5208235 (1993-05-01), Poss
patent: 5212177 (1993-05-01), Poss
patent: 5225408 (1993-07-01), Weller
patent: 5256695 (1993-10-01), Poss
patent: 5374615 (1994-12-01), Poss
patent: 5378704 (1995-01-01), Weller
patent: 5428033 (1995-06-01), Belley
patent: 5470975 (1995-11-01), Atwal
patent: 5512681 (1996-04-01), Boswell
patent: 5519143 (1996-05-01), Harris
patent: 5534347 (1996-07-01), Chen
patent: 5736297 (1998-04-01), Roeschert
patent: 5895771 (1999-04-01), Epstein
patent: 5977413 (1999-11-01), Tomaru
patent: 197 16 231 (1998-10-01), None
patent: 197 22 952 (1998-12-01), None
patent: 0 296 722 (1988-12-01), None
patent: 0 481 448 (1992-04-01), None
patent: 0 547 442 (1993-06-01), None
patent: 0 556 060 (1993-08-01), None
patent: 0 733 366 (1996-09-01), None
patent: 0 733 614 (1998-05-01), None
patent: 0 916 352 (1998-12-01), None
patent: 2 784 114 (2000-04-01), None
patent: 2 321 244 (1998-07-01), None
patent: 2 337 701 (1999-01-01), None
patent: 05 124925 (1993-09-01), None
patent: 08 311036 (1996-11-01), None
patent: 09 012585 (1997-01-01), None
patent: 1825496 (1994-12-01), None
patent: 1743153 (1995-02-01), None
patent: 0 144 101 (1985-06-01), None
patent: WO 87/05297 (1987-09-01), None
patent: WO 91/00277 (1991-01-01), None
patent: WO 91/00281 (1991-01-01), None
patent: WO 92/00067 (1992-01-01), None
patent: WO 93/21158 (1993-10-01), None
patent: WO 93/21168 (1993-10-01), None
patent: WO 94/10692 (1994-05-01), None
patent: WO 94/14453 (1994-07-01), None
patent: WO 94/15932 (1994-07-01), None
patent: WO 9418606 (1994-08-01), None
patent: WO 95/29904 (1995-11-01), None
patent: WO 95/35311 (1995-12-01), None
patent: WO 95/35312 (1995-12-01), None
patent: WO 95/35313 (1995-12-01), None
patent: WO 96/13491 (1996-05-01), None
patent: WO 96/13500 (1996-05-01), None
patent: WO 98/25913 (1998-06-01), None
patent: WO 99/12938 (1999-03-01), None
patent: WO 99/47497 (1999-09-01), None
patent: WO 99/65884 (1999-12-01), None
patent: WO 00/09710 (2000-02-01), None
patent: WO 00/20472 (2000-04-01), None
patent: WO 00/34344 (2000-06-01), None
patent: WO 00/37422 (2000-06-01), None
patent: WO 00/46203 (2000-08-01), None
patent: WO 00/54759 (2000-09-01), None
patent: WO 00/56710 (2000-09-01), None
patent: WO 00/69810 (2000-11-01), None
patent: WO 01/03705 (2001-01-01), None
patent: WO 02/058690 (2002-08-01), None
patent: WO 02/058698 (2002-08-01), None
patent: WO 02/064136 (2002-08-01), None
patent: WO 02/066034 (2002-08-01), None
patent: WO 02/066035 (2002-08-01), None
Martin, Yvonne C. et al. “Do Structurally Similar Molecules Have Similar Biological Activity?” Journal of Medicinal Chemistry 2002, 45, 4350-4356.
Cheng et. al., “Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors” Bioorganic & Medicinal Chemistry Letters 2006, 16, 695-700.
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker (Modern Pharmaceutics) Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Abo-Hashema, et al., Biochemistry, 1999, 15840-15847, vol. 38.
Abo-Hashema, et al., Journal of Biological Chemistry, 1999, 35577-35582, Vo. 274, No. 50.
Alam and Saggerson, Biochen J., 1998, 233-241, vol. 334.
An, et al., Journal of Biochemistry and Molecular Biology, 1999, 414-418, vol. 32, No. 4.
Anderson, Current Pharmaceutical Design, 1998, 1-16, vol. 4, No. 1.
Buckner, et al., Archives of Biochemistry and Biophysics, 1976, 539-551, vol. 177.
Deems, et al., The American Physiological Society, 1998, R524-R528, vol. 274.
Dyck, et al., The American Physiological Society, 1998, H2122-H2129, vol. 275.
Fitzpatrick, et. al., Am. J. Hum. Genet. 1999, 318-326, vol. 65.
Fraser, et al., Febs Letters, 1999, 69-74, vol. 446.
Gao, et al., Journal of Lipid Research, 1999, 178-182, vol. 40.
Hearse, Metabolic Approaches to Ischaemic Heart Disease and its Management, Science Press, London, UK.
Jang, et al., The Journal of Biological Chemistry, 1989, 3500-3505, vol. 264, No. 6.
Kantor, et al., Circulation Research, 2000, 580-588, vol. 86.
Kennedy, et. al., Biochemical Pharmacology, 1996, 273-280, vol. 52.
Kim and Kolattukudy, Archives of Biochemistry and Biophysics, 1978, 585-597, vol. 190, No. 2.
Kim and Kolattukudy, Archives of Biochemistry and Biophysics, 1978, 234-246, vol. 190, No. 1.
Kim and Kolattukudy, Biochimica et Biophysica Acta, 1978, 187-196, vol. 531.
Loftus, et al., Science, 2000, 237-238, vol. 288.
McCormack, et al., Gen. Pharmac., 1998, 639-645, vol. 30, No. 5.
McGarry and Brown, Eur. J. Biochem, 1997, 1-14, vol. 244.
McNeill, Measure of cardiovascular Func., CRC Press, Boca Raton, USA.
Pepine and Wolff, The American Journal of Cardiology, 1999, 46-50, vol. 84.
Pizer, et al., Cancer Research, 2000, 213-218, vol. 60.
Prentki and Corkey, Diabetes, 1996, 273-283, vol. 45.
Randle, et al., Lancet, 1963, 785-789, vol. 1.
Sacksteder, et al., The Journal of Biological Chemistry, 1999, 24461-24468, vol. 274, No. 35.
Voilley, et al., Biochem J., 1999, 213-217, vol. 340.
Wargovich, et. al., Am J Cardiol, 1988, 65-70, vol. 61.
Zammit, Biochemical Society, 1999, 505-515, vol. 343.
Database Biosis ′Online!, Biosciences Information Service, 1976, Database accession No. PREV197763044218, 002207355.
Chemical Abstracts, 1969, vol. 71, No. 23, Columbus, OH., US; XP002207359.
“Fluka Chemika-Biochemika” Fluka Chemie AG, Buchs (CH), XP002230053, 1995, 331.
Arrhenius Thomas
Chen Mi
Cheng Jie Fei
Dyck Jason R.
Lopaschuk Gary D.
Chugai Seiyaku Kabushiki Kaisha
Desai Rita
Fish & Richardson P.C.
O'Dell David K
LandOfFree
Piperidine compounds useful as malonyl-CoA decarboxylase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine compounds useful as malonyl-CoA decarboxylase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine compounds useful as malonyl-CoA decarboxylase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4041703